PM-181104

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NamePM-181104
Drug Alias Nameantimicrobial (NPIL Research & Development)antimicrobial (Piramal Life Sciences)antimicrobial (Piramal Healthcare)PM-181104
ClassificationNatural product/ExtractBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPiramal Enterprises Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsBacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A